Voyager Therapeutics
VYGR
VYGR
98 hedge funds and large institutions have $418M invested in Voyager Therapeutics in 2017 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 37 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
38.03% more ownership
Funds ownership: 42.06% → 80.08% (+38%)
31% more funds holding
Funds holding: 75 → 98 (+23)
Holders
98
Holding in Top 10
2
Calls
$1.84M
Puts
$1.26M
Top Buyers
| 1 | +$25.6M | |
| 2 | +$8.54M | |
| 3 | +$8.09M | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$7.68M |
| 5 |
Axa
Paris,
France
|
+$5.59M |
Top Sellers
| 1 | -$8.19M | |
| 2 | -$6.82M | |
| 3 | -$5.31M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$4.88M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.69M |